Ovulation-promoting therapy, which is supraphysiological because it interferes with the physiological mechanisms of the growth of a single dominant follicle, can be used in both normally ovulating and anovulatory women, and is the basis for improving the success rate of in vitro fertilization embryo transfers and facilitating the development of assisted reproduction techniques and their derivatives.